(Q44658044)

English

‘Passive stabilization’ of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6‐OHDA‐lesioned rat

scientific article published on December 1, 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

‘Passive stabilization’ of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6‐OHDA‐lesioned rat (English)

reason for preferred rank

most precise value

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

"Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622102

2 April 2024

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

author name string

Brian P. Bergstrom

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622102

2 April 2024

Paul A. Garris

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622102

2 April 2024

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1471-4159.2003.02104.x

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1471-4159.2003.02104.x

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1224-1236

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical Parkinsonism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.02104.X

21 January 2018

Color images for fast-scan CV measurements in biological systems

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.02104.X

21 January 2018

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

1

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Parkinson's disease: pathophysiology

2

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury

3

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes

5

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Utility of a tripolar stimulating electrode for eliciting dopamine release in the rat striatum

6

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism

7

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach

8

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse

9

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.

10

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

11

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Microelectrodes for the measurement of catecholamines in biological systems

13

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Medial Dorsal Striatum Is More Sensitive Than Lateral Dorsal Striatum to Cocaine Inhibition of Exogenous Dopamine Clearance: Relation to [3H]Mazindol Binding, but Not Striosome/Matrix

14

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra

15

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Quantification of the dopamine innervation in adult rat neostriatum

16

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum

18

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.

19

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

20

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Mammalian neural stem cells

21

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Modeling fast dopamine neurotransmission in the nucleus accumbens during behavior

22

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study

23

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

24

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Heterogeneity of evoked dopamine overflow within the striatal and striatoamygdaloid regions

25

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals

26

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems.

27

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

28

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs

30

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons

31

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.

32

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Role of inflammation in the pathogenesis of Parkinson's disease: models, mechanisms, and therapeutic interventions.

35

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Firing modes of midbrain dopamine cells in the freely moving rat.

36

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Profound neuronal plasticity in response to inactivation of the dopamine transporter

37

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.

38

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum

39

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

40

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

41

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Parkinson's disease. Second of two parts

42

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum

43

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

The Freezing of Time as a Presenting Symptom of Parkinson's Disease

44

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions

45

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons

48

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Levodopa motor complications in Parkinson's disease

49

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Etiology and pathogenesis of Parkinson's disease

50

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

51

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Subsecond dopamine release promotes cocaine seeking.

52

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine

53

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

An ultrastructural size principle

54

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

55

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

The effect of acute kainic acid treatment on dopamine D2 receptors in rat brain

56

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Sub-second changes in accumbal dopamine during sexual behavior in male rats

57

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system.

58

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study

59

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury

60

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Predictive reward signal of dopamine neurons

62

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

63

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets

64

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

65

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Immunocompetence, ornamentation, and viability of male barn swallows (Hirundo rustica)

67

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage

68

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

69

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Real-time characterization of dopamine overflow and uptake in the rat striatum

71

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study

72

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.

73

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry

74

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

75

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism

76

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

78

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease

79

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

The emergence of the volume transmission concept1Published on the World Wide Web on 12 January 1998.1

80

1 reference

10.1046/J.1471-4159.2003.02104.X

https://api.crossref.org/works/10.1046/J.1471-4159.2003.02104.X

2 April 2024

Identifiers

10.1046/J.1471-4159.2003.02104.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44658044&oldid=2117542942"